Activation of p90(RSK) and cAMP response element binding protein in stimulated neutrophils: Novel effects of the pyridinyl imidazole SB 203580 on activation of the extracellular signal-regulated kinase cascade

Journal of Immunology

Volumn 163, Issue 8, 1999, Pages 4527-4536

  Lian, Jian P ^a   Huang, RiYun ^b   Robinson, Dwight ^b   Badwey, John A ^a,c  

^a HARVARD MEDICAL SCHOOL   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c BOSTON BIOMEDICAL RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; FORMYLMETHIONYLLEUCYLPHENYLALANINE; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN KINASE; PROTEIN P90; SYNAPTOPHYSIN; UNCLASSIFIED DRUG; ENZYME INHIBITOR; FLAVONOID; IMIDAZOLE DERIVATIVE; MITOGEN ACTIVATED PROTEIN KINASE P38; PYRIDINE DERIVATIVE; S6 KINASE;

ANIMAL CELL; ARTICLE; CELL STIMULATION; CONTROLLED STUDY; DRUG MECHANISM; ENZYME ACTIVATION; ENZYME DENATURATION; ENZYME MECHANISM; ENZYME SUBSTRATE; GUINEA PIG; INFLAMMATION; NEUTROPHIL; NONHUMAN; PHAGOCYTOSIS; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; ANIMAL; DRUG ANTAGONISM; DRUG EFFECT; ENZYMOLOGY; HUMAN; IMMUNOLOGY; LEUKOCYTE ACTIVATION; METABOLISM; PHOSPHORYLATION; PROTEIN RENATURATION; SIGNAL TRANSDUCTION;

ANIMALS; CYCLIC AMP RESPONSE ELEMENT-BINDING PROTEIN; ENZYME ACTIVATION; ENZYME INHIBITORS; FLAVONOIDS; GUINEA PIGS; HUMANS; IMIDAZOLES; MAP KINASE SIGNALING SYSTEM; MITOGEN-ACTIVATED PROTEIN KINASES; NEUTROPHIL ACTIVATION; NEUTROPHILS; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLATION; PROTEIN RENATURATION; PYRIDINES; RIBOSOMAL PROTEIN S6 KINASES; RIBOSOMAL PROTEIN S6 KINASES, 90-KDA;

EID: 0032589380     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (60)

1. Ding, J., and J. A. Badwey. 1993. Neutrophils stimulated with a chemotactic peptide or a phorbol ester exhibit different alterations in the activities of a battery of protein kinases. J. Biol. Chem. 268:5234.
2. phox and MARKS. J. Biol. Chem. 268:17326.
3. Grinstein, S., W. Furuya, J. R. Butler, and J. Tseng. 1993. Receptor mediated activation of multiple serine/threonine kinases in human neutrophils. J. Biol. Chem. 268:20233.
4. Ding, J., U. G. Knaus, J. P. Lian, G. M. Bokoch, and J. A. Badwey. 1996. The renaturable 69 and 63 kDa protein kinases that undergo rapid activation in chemoattractant-stimulaled guinea pig neutrophils are p21-activated kinases (Paks). J. Biol. Chem. 271:24869.
5. Brumell, J. H., and S. Grinstein. 1994. Serine/threonine kinase activation in human neutrophils: relationship to tyrosine phosphorylation. Am. J. Physiol. 267: C1574.
6. Ding, J., C. J. Vlahos, R. Liu, R. F. Brown, and J. A. Badwey. 1995. Antagonists of phosphatidylinositol 3-kinase block activation of several novel protein kinases in neutrophils. J. Bint. Chem. 270:11684.
7. Grinstein, S., and W. Furuya. 1992. Chemoattractant-induced tyrosine phosphorylation and activation of microtubule-associated protein kinase in human neutrophils. J. Biol. Chem. 267:18122.
8. Torres, M., F. L. Hall, and K. O'Neil. 1993. Stimulation of human neutrophils with formyl-methionyl-leucyl-phenylalanine induces tyrosine phosphorylation and activation of two distinct mitogen-activated protein kinases. J. Immunol. 150:1563.
9. Thompson, H. L., M. Shiroo, and J. Saklalvala. 1993. The chemotactic factor N-formylmethionyl-leucyl-phenylalanine activates microtubule-associated protein 2 (MAP) kinase and a MAP kinase kinase in polymorphonuclear leukocytes. Biochem. J. 290:483.
10. Worthen, G. S., N. Avdi, A. M. Buhl, N. Suzuki, and G. L. Johnson. 1994. FMLP activates Ras and Raf in human neutrophils: potential role in activation of MAP kinase. J. Clin. Invest. 94:815.
11. Nahas, N., T. F. P. Molski, G. A. Fernandez, and R. I. Sha'afi. 1999. Tyrosine phosphorylation and activation of a new mitogen-activated protein (MAP)-kinase cascade in human neutrophils stimulated with various agonists. Biochem. J. 318: 247.
12. Nick, J. A., N. J. Avdi, S. K. Young, C. Knall, P. Gerwins, G. L. Johnson, and G. S. Worthen. 1997. Common and distinct intracellular signaling pathways in human neutrophils utilized by platelet activating factor and fMLP J. Clin. Invest. 99:975.
13. Krump, E., J. S. Sanghera, S. L. Pelech, W. Furuya, and S. Grinstein. 1997. Chemotactic peptide N-formyl-Met-Leu-Phe activation of p38 mitogen-activated protein kinase (MAPK) and MAPK-activated protein kinase-2 in human neutrophils. J. Biol. Chem. 272:937.
14. Davis, R. J. 1993. The mitogen-activated protein kinase signal transduction pathway. J. Biol. Chem. 268:14553.
15. Alessi, D. R., A. Cuenda, P. Cohen, D. T. Dudley, and A. R. Saltiel. 1995. PD 98059 is a specific inhibitor of the activation of mitogen-activated protein kinase kinase in vitro and in vivo. J. Biol. Chem. 270:27489.
16. Lee, J. C., J. T. Laydon, P. C. McDonnell, T. F. Gallagher, S. Kumar, D. Green, D. McNulty, M. J. Blumenthal, J. R. Heys, S. W. Landvatter, et al. 1994. A protein kinase involved in the regulation of inflammatory cytokine biosynthesis. Nature 372:739.
17. Avdi, N. J., B. W. Winston, M. Russel, S. K. Young, G. L. Johnson, and G. S. Worthen. 1996. Activation of MEKK by formyl-methionyl-leucyl-phenyl-alanine in human neutrophils: mapping pathways for mitogen-activated protein kinase activation. J. Biol. Chem. 52:33598.
18. Suchard, S. J., P. J. Mansfield, L. A. Boxer, and J. A. Shayman. 1997. Mitogen-activated protein kinase activation during IgG-dependent phagocytosis in human neutrophils. J. Immunol. 158:4961.
19. Kuroki, M., and J. T. O'Flaherty. 1997. Differential effects of a mitogen-activated protein kinase inhibitor on human neutrophil responses to chemolactic factors. Biochem. Biophys. Res. Commun. 232:474.
20. Downey, G. P., J. R. Butler, H. Tapper, L. Fialkow, A. R. Saltiel, B. R. Rubin, and S. Grinstein. 1997. Importance of MEK in neutrophil microbicidal responsiveness. J. Immunol. 160:434.
21. Zu. Y.-L., J. Qi, A. Gilchrist, G. A. Fernandez, D. Vazquez-Abad, D. L. Kreutzer, C.-K. Huang, and R. I. Sha'afi. 1998. p38-mitogen activated protein kinase activation is required for human neutrophil function triggered by TNF-α or fMLP stimulation. J. Immunol. 160:1982.
22. 2-integrin-dependent neutrophil adhesion and the adhesion-dependent oxidative burst. J. Immunol. 161:1921.
23. phox as determined by two-dimensional phosphopeptide mapping: phosphorylation by protein kinase C, protein kinase A, and a mitogen-activated protein kinase. J. Biol. Chem. 271:6374.
24. Durstin, M., S. Durstin, T. F. P. Molski. E. L. Becker, and R. I. Sha'afi. 1994. Cytoplasmic phospholipase A2 translocates to membrane fraction in human neutrophils activated by stimuli that phosphorylate mitogen-activated protein kinase. Proc. Natl. Acad. Sci. USA 91:3142.
25. Zu, Y.-L., Y. Ali, A. Gilchrist, M. E. Labadia, R. I. Sha'afi, and C. K. Huang. 1996. Activation of MAP kinase-activated protein kinase 2 in human neutrophils after phorbol ester or fMLP peptide stimulation. Blood 87:5287.
26. Huang, C.-K., L. Zhan, Y. Ali, and J. Jongstra. 1997. LSP1 is the major substrate for mitogen-activated protein kinase-activated protein kinase 2 in human neutrophils. J. Biol. Chem. 272:17.
27. Badger, A. M., J. N. Bradbeer, B. Votta, J. C. Lee, J. L. Adams, and D. E. Griswold. 1996. Pharmacological profile of SB 203580, a selective inhibitor of cytokine suppressive binding protein/p38 kinase, in animal models of arthritis, bone resorption, endotoxin shock and immune function. J. Pharmacol. Exp. Ther. 279:1453.
28. Xing, J., P. D. Ginty, and M. E. Greenberg. 1996. Coupling of the RAS-MAPK pathway to gene activation by RSK2, a growth factor-regulated CREB kinase. Science 273:959.
29. Badwey, J. A., and M. L. Karnovsky. 1986. NADH-oxidase and aldehyde oxidase from polymorphonuclear leukocytes. Methods Enzymol. 132:365.
30. Promega Corp. 1998. Promega Technical Bulletin No. 262. Promega, Madison, WI.
31. Pierce Chemical Co. 1996. SuperSignal Substrate Western Blotting Kits. No. 34081-34086. Pierce Chemical Co., Rockford, IL.
32. Huang, R., J. P. Lian, D. Robinson, and J. A. Badwey. 1998. Neutrophils stimulated with a variety of chemoattractanls exhibit rapid activation of p21-activated kinases (Paks): separate signals are required for activation and inactivation of Paks. Mol. Cell. Biol. 18:7130.
33. Lian, J. P., and J. A. Badwey. 1997. Activation of the p21-activated protein kinases from neutrophils with an antibody that reacts with the N-terminal region of Pak 1. FEBS Lett. 404:211.
34. Young, P. R., M. M. McLaughlin, S. Kumar, S. Kassis, M. L. Doyle, D. McNulty, T. F. Gallagher, S. Fisher, P. C. McDonnell, S. A. Carr, et al. 1997. Pyridinyl imidazole inhibitors of p38 mitogen-activated protein kinase bind in the ATP site. J. Biol. Chem. 272:12116.
35. Frantz, B., T. Klatt, M. Pang, J. Parsons, A. Rolando, H. Williams, M. J. Tocci, S. J. O'Keefe, and E. A. O'Neill. 1998. The activation state of p38 mitogen activated protein kinase determines the efficiency of ATP competition for pyridinylimidazole inhibitor binding. Biochemistry 37:13846.
36. Sturgill, T. W., L. B. Ray, E. Erickson, and J. L. Maller. 1988. Insulin stimulated MAP2 kinase phosphorylates and activates ribosomal protein S6 kinase. Nature 334:715.
37. Blenis, J. 1993. Signal transduction via the MAP kinases: proceed at your own RSK. Proc. Natl. Acad. Sci. USA 90:5889.
38. rsk that are inducible by MAPK. J. Biol. Chem. 27:1496.
39. Leighton. I. A., K. N. Dalby, F. B. Caudwell, P. T. W. Cohen, and P. Cohen. 1995. Comparison of the specificities of p70 S6 kinase and MAPKAP kinase-1 identifies a relatively specific substrate for p70 S6 kinase: the N-terminal kinase domain of MAPKAP kinase-1 is essential for peptide phosphorylation. FEBS Lett. 375:289.
40. Hsiao, K.-M., S.-Y. Chou, S.-J. Shih, and J. E. Ferrell, J. 1994. Evidence that inactive p42 mitogen-activated protein kinase and inactive Rsk exist as a heterodimer in vivo. Proc. Natl. Acad Sci. USA 91:5480.
41. rsk isoforms with mitogen-activated protein kinases. J. Biol. Chem. 271: 29773.
42. Cuenda, A., J. rouse, Y. N. Doza, R. Meier, P. Cohen, T. F. Gallagher, R. R. Young, and J. C. Lee. 1995. SB 203580 is a specific inhibitor of a MAP kinase homologue which is stimulated by cellular stresses and interleukin-1. FEBS Lett. 364:229.
43. Borsch-Haubold, A. G., S. Pasquet, and S. P. Watson. 1998. Direct inhibition of cyclooxygenase-1 and -2 by the kinase inhibitors SB 203580 and PD 98059: SB 203580 also inhibits thromboxane synthase. J. Biol. Chem. 273:28766.
44. Heyworth, P. G., and J. A. Badwey. 1990. Protein phosphorylatior associated with the stimulation of neutrophils. Modulation of superoxide production by protein kinase C and calcium. J. Bioenerg. Biomemb. 1052:1.
45. Marais, R., Y. Light, C. Mason, H. Paterson, M. F. Olson, and C. J. Marshall. 1998. Requirement of Ras-GTP-Raf complexes for activation of Raf-1 by protein kinase C. Science 280:109.
46. rsk) phosphorylates the N-terminal regulatory domain of 1κBα and stimulates its degradation in vitro. J. Biol. Chem. 272:2181.
47. Tan, Y., J. Rouse, A. Zhang, S. Cariati, P. Cohen, and M. J. Comb. 1996. FGF and stress regulate CREB and ATF-1 via a pathway involving p38 MAP kinase and MAPKAP kinase 2. EMBO J. 15:4629.
48. Montminy, M. 1997. Transcriptional regulation by cyclic AMP. Annu. Rev. Biochem. 66:807.
49. Hidaka, H., M. Inogaki, S. Kawamoto, and Y. Sasaki. 1984. Isoquinolinesulfonamides, novel and potent inhibitors of cyclic nucleotide dependent protein kinases and protein kinase C. Biochemistry 23:5036.
50. Vollebregt, M., M. B. Hampton, and C. C. Winterboum. 1998. Activation of NF-κB in human neutrophils during phagocytosis of bacteria independently of oxidant generation. FEBS Lett. 432:40.
51. Jones, S. W., E. Erickson, J. Blenis, J. L. Mailer, and R. L. Erickson. 1988. A Xenopus ribosomal protein S6 kinase has two apparent kinase domains that are each similar to distinct protein kinases. Proc. Natl. Acad. Sci. USA 85:3377.
52. Kumar, S., M. J. Orsin, J. C. Lee, P. C. McDonnell, C. Debouk, and P. R. Young. 1996. Activation of the HIV-long terminal repeat by cytokines and environmental stress requires an active CSBP/p38 MAP kinase. J. Biol. Chem. 271:30864.
53. Shapiro, L., K. A. Heidenreich, M. K. Meintzer, and C. A. Dinarello. 1998. Role of p38 mitogen-activated protein kinase in HIV type 1 production in vitro. Proc. Natl. Acad. Sci. USA 95:7422.
54. Frasch, S. C., J. A. Nick, V. A. Fadok, D. L. Bratton, G. S. Worthen, and P. M. Henson. 1998. p3g-Mitogen-activated protein kinase-dependent and -independent intracellular signal transduction pathways leading to apoptosis in human neutrophils. J. Biol. Chem. 273:8389.
55. Marshall, L. A., M. J. Hansbury, B. J. Bolognese, R. J. Gum, P. R. Young, and R. J. Mayer. 1998. Inhibitors of p38 mitogen-activated kinase modulate IL-4 induction of low affinity IgE receptor (CD23) in human monocytes. J. Immunol. 161:6005.
56. Badger, A. M., M. N. Cook, M. W. Lark, T. M. Newman-Tarr, B. A. Swift, A. H. Nelson, F. C. Barone, and S. Kumar. 1998. SB 203580 inhibits p38-mitogen-activated protein kinase, nitric oxide production, and inducible nitric oxide synthase in bovine cartilage-derived chondrocytes. J. Immunol. 161:467.
57. Hale, K. K., D. Trollinger, M. Rihanek, and C. L. Manthey. 1999. Differential expression and activation of p38 mitogen-activated protein kinase α, β, γ, and δ in inflammatory cell lineages. J. Immunol. 162:4246.
58. Downey, G. P., J. Butler, J. Brummell, N. Borregaard, A. Sue-A-Quan, and S. Grinstein. 1996. Chemotactic peptide-induced activation of MEK-2, the pre-dominant isoform in human neutrophils: inhibition by wortmannin. J. Biol. Chem. 271:21005.
59. 2+/calmodulin-dependent protein kinase. IV. Role in transcriptional regulation. J. Biol. Chem. 269:15520.
60. rsk2. J. Biol. Chem. 274:3385.